Announcements Trials
Browse Landscape

Phase

Phase 2/3 2

Status

Recruiting 2

Sponsor Class

OTHER 18OTHER_GOV 2NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2NET 1Head & Neck 1Gynecologic 1Genitourinary 1Endocrine 1

Conditions

Pancreatic Neoplasms 1Disease 1Colonic Neoplasms 1

Interventions

Oxaliplatin 30Capecitabine 26Fluorouracil 20Irinotecan 19tislelizumab 18apatinib 16Paclitaxel 13Cisplatin 13S 1 (combination) 12Radiotherapy 12Leucovorin 11Bevacizumab 11Laparoscopy 9Drug Therapy 9Cetuximab 9sintilimab 8Endoscopic Mucosal Resection 8Gemcitabine 7Docetaxel 7camrelizumab 6XELOX 6Surgical Procedures, Operative 6Radiation 6Propranolol 6Nivolumab 6Neoadjuvant Therapy 6Immune Checkpoint Inhibitors 6Folfox protocol 6Levoleucovorin 5HMPL-013 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Positron Emission Tomography Computed Tomography × Gastrointestinal × Clear all
NCT07272772 2025-12-09

Colon Cancer Diagnosis With FAPI-PET Imaging

Turku University Hospital

Phase 2/3 Recruiting
100 enrolled
Gastrointestinal

Colonic Neoplasms

NCT07098598 2025-08-01

Pancreatic Cancer Diagnosis With FAPI-PET Imaging

Turku University Hospital

Phase 2/3 Recruiting
100 enrolled
Gastrointestinal

Disease, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡